Vaccitech Plc

( )
VACC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.93%54.040.9%$1956.39m
JNJJohnson & Johnson -0.82%165.210.7%$952.05m
ABBVAbbVie, Inc. -1.62%133.021.9%$896.21m
MRKMerck & Co., Inc. -0.69%80.730.7%$844.40m
BMYBristol-Myers Squibb Co. -0.17%64.611.0%$686.91m
LLYEli Lilly & Co. -0.76%243.201.1%$618.39m
AZNAstraZeneca Plc 1.16%60.171.0%$237.52m
NVSNovartis AG -0.75%88.180.2%$191.03m
GSKGlaxoSmithKline Plc -1.77%44.880.2%$165.07m
NVONovo Nordisk A/S -1.86%95.480.1%$149.54m
VTRSViatris, Inc. -0.54%14.640.0%$136.21m
RGENRepligen Corp. -0.59%188.466.7%$100.63m
ALLKAllakos, Inc. -3.37%7.180.0%$85.67m
IMMXImmix Biopharma, Inc. -4.24%5.420.0%$85.35m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.87%116.040.0%$75.90m

Company Profile

Vaccitech Plc operates as a holding company. It is engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company was founded in March 2021 and is headquartered in Oxford, the United Kingdom.